Home > Boards > Other Markets > ETFs > iPath S&P 500 VIX Short-Term Futures ETN (VXX)

Basically, when economies are open, covid is a

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
luisWinthorpIII Member Profile
 
Followed By 0
Posts 113
Boards Moderated 0
Alias Born 04/19/18
160x600 placeholder
Home Depot Won a Lot of Customers During the Pandemic. The Trick Is Keeping Them. -- Journal Report
Home Depot Inc. reacted to the rapid spread of Covid-19 in the U.S. by canceling annual sales events and pulling many marked-down goods off the shelves to keep crowds away from stores. But rather than a drop in traffic, amid lockdowns and social distancing, customers began flocking to its physical and online stores, spending stay-at-home savings and government stimulus checks on home-improvement projects.
To Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding With Its Biggest Competitors
Alphabet, Netflix, Tesla: Stocks That Defined the Week
Correction to Facebook Article
Pivotal Studies of Covid-19 Vaccines From AstraZeneca, J&J Resuming -- 3rd Update
Facebook Seeks Shutdown of NYU Research Project Into Political Ad Targeting -- Update
CNN President Jeff Zucker Faces What Might Be His Last Lap
Top Company News of the Day
Top Stories of the Day
DOJ Greenlights Liberty Latin America's Acquisition of AT&T's Operations in Puerto Rico, U.S. Virgin Islands
Pivotal Study of J&J's Covid-19 Vaccine to Resume, Company Says
Stocks Snap Three-Week Winning Streak
U.S. Bonds Yields Remain Near Highest Level Since June -- Update
Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S. -- 2nd Update
American Express Expects Net Interest Income to be Sequentially Flat in 4Q
Wheat Bounces Back on New Export Purchases
Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S. -- Update
Goldman Seizing or Withholding $174 Million From Executives for 1MDB Case -- 5th Update
McDonald's Seeks Dismissal of Discrimination Lawsuit Filed by Black Former Franchisees
GDP Expected to Recover -- Data Week Ahead
China's Import Surge Drives Optimism in Dry-Bulk Shipping Demand
luisWinthorpIII   Wednesday, 08/12/20 10:10:37 PM
Re: None
Post # of 2862 
Basically, when economies are open, covid is a market catalyst

The market doesn’t care if your grandma or your baby sister dies of covid - it only cares that the economy is open for business.

And the vaccine will make epicenter stocks explode. It would be wise to get into airline and hotel stocks - not sure if right now is the time or possibly a week or 2 from now till they hit a lower shelf, but the time is approaching where either vaccine news will come out from any of the vaccine manufacturers or we will get an agreement on stimulus. And keep in mind, with multiple manufactures, PRs seem to be coming out every week - so there is plenty of vaccine news to prop the market up for now. And Assuming there is any money at all for airlines, epicenter stocks will explode. This is all in anticipation over the next few months and will continue to prop the market up until either event occurs. There will be small pockets of opportunity for vxx (if you time it right) but ultimately it’s almost impossible to time those windows just right to make it worth your while. If the stimulus comes well before October, there will likely be plenty of opportunity with vxx because the FED is just about out of bullets and the Biden polls are going to create uncertainty for Wall Street. The only thing that can save the market after the stimulus is a vaccine. And the fact that we have these major catalysts in place is not good for taking a position in VXX long term. And if you do, be careful, trump could continue to use executive power to push the mRNA trial along. He is not happy that Putin beat him to the punch (regardless if the Russian vaccine is good or not) and he knows a vaccine could be the difference in him getting re-elected. He is going to be pushing hard to move as fast as possible, so dont be surprised if we get expedited vaccine results and emergency FDA approval sooner than the estimated clinical trial completion date states. And with trumps entire election on the line, with so much to lose, there is a good chance there could be some political intervening going on to ensure mRNA (or a worthy competitor) wins regardless of what the science really says. Obviously, a vaccine is not the only factor at play for trump, but it is the catalyst that will get the epicenter portions of the market rebooted and if the economy looks good prior to the election - he will get the credit regardless if he deserves it. So there are major catalysts in the market ahead of us with big Political incentives for the current administration to get the economy to all time highs prior to the election. As a result, stay away from vxx for now. If mRNA fails though (or competitors if they actually get there first), if you are not in Vxx before the news comes out, you will have missed a major opportunity. For me, thats just too much of a gamble. There’s no evidence from top officials that any concerns are present with the ongoing trials of the major vaccine players.



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences